Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

4-Week, Multi-Center, Randomized, Db-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety & Efficacy of Tenapanor for the T/t of IBS-C in Pts. 6 to < 12 Yrs. Old

NCT06553547 is registered in ClinicalTrials.gov with Ardelyx as lead sponsor.

NCT NCT06553547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06553547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
4-Week, Multi-Center, Randomized, Db-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety & Efficacy of Tenapanor for the T/t of IBS-C in Pts. 6 to < 12 Yrs. Old
Lead sponsor
Ardelyx
Phase
Phase 2
Overall status
Completed
Start date
July 24, 2024
Completion date
July 7, 2026
Enrollment
72 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome with constipation (ibs-c)